SAM #75N98027Q00057

NIH NICHD seeks Bio-Rad QX700 E Droplet Digital PCR System

The National Institutes of Health’s National Institute of Child Health and Human Development seeks a Bio-Rad digital PCR system for nucleic-acid analysis. - Buyer: National Institutes of Health (NIH), National Institute of Child Health and Human Development (NICHD); no further office is specified. - OEM: BIO-RAD / BioRad Laboratories, Inc. is identified as the original manufacturer and sole supplier. - Requested product: Bio-Rad QX700 E Droplet Digital PCR System; quantity and part number are not specified. - The system is intended for absolute nucleic-acid quantification without standard curves and offers 7-color multiplexing, integrated walkaway operation, and run setup and analysis software. - Supports 16, 32, or up to 48 samples per run. - The procurement is proposed as sole source; the notice describes the system’s technical and operational capabilities as the basis for the requirement.

Description

The National Institutes of Health (NIH), National Institute of Child Health and Human Development (NICHD), intends to award a contract to BIO-RAD on a sole-source basis  pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or  Services Will Satisfy Agency Requirements, for the acquisition of QX700 E Droplet Digital  PCR System, the Government intends to solicit and award a Purchase Order on a solesource basis because the Government's minimum technical requirements will be satisfied  by BIO-RAD. DTM’s shared labs have ongoing experiments that require very precise assessment of sample quality and  quantity. The QX700 E Droplet Digital PCR System delivers the power of absolute quantification for our  labs — without the need for standard curves. With simple setup, intuitive analysis, and 7-color multiplexing,  it makes digital PCR more accessible than ever. All-in-one, integrated instrument enabling walkaway  operation. Intuitive software with a user-friendly interface for easy run setup and data analysis. Generates  absolute quantification results with intuitive software. A compact system built for low throughput or ad hoc  studies and shared research spaces. Supports from 16, 32, or up to 48 samples per run, ensuring flexibility  for low-throughput laboratories. The QX700 E Droplet Digital PCR System* delivers the power of absolute quantification for our labs — without the need for standard curves. With simple setup, intuitive analysis, and 7-color  multiplexing, it makes digital PCR more accessible than ever. All-in-one, integrated instrument  enabling walkaway operation. Intuitive software with a user-friendly interface for easy run setup  and data analysis. Generates absolute quantification results with intuitive software. A compact  system built for low throughput or ad hoc studies and shared research spaces. Supports from 16,  32, or up to 48 samples per run, ensuring flexibility for low-throughput laboratories. BioRad Laboratories, Inc. is the original manufacturer and sole supplier of the QX700 E Droplet  Digital PCR System. This piece of equipment utilizes Droplet Digital PCR for the absolute  quantification of nucleic acids. This notice is not a request for competitive quotations. However, interested parties that believe  they can meet the Government's requirements may submit a capability statement demonstrating  their ability to provide the required supplies and meet all specified technical and operational  requirements. The Government will consider all timely capability statements received and determine whether  the acquisition should proceed as a sole-source procurement or be competed. The Government anticipates making an award approximately five (5) calendar days after the  closing date of this notice, unless the Government determines that another responsible source is  capable of meeting the requirement. Capability statements shall be submitted electronically to davisroshonna@mail.nih.gov no later  than 9:00 a.m. EDT on November 18, 2026. Please reference Notice No. 75N98027Q00057 in the subject line of the response.

View original listing